Literature DB >> 65433

Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

R S Baltimore, D L Kasper, C J Baker, D K Goroff.   

Abstract

An opsonophagocytic assay has been developed which requires human polymorphonuclear leukocytes, immune serum, and complement for optimal killing of Group B streptococci. Only with all three of these components was killing of greater than 1.0 log10 of the initial inoculum achieved, using rabbit antisera directed to homologous strains of each of the five known serotypes of Group B streptococci. Titers of specific antisera which opsonized the strains and resulted in greater than 1 log 10 reduction of colony-forming units, ranged from 1:100 (serotype Ib) to 1:3200 (serotype Ia). Cross-reactions between serotype-specific sera and heterologous strains were seen in certain instances. Type Ic strain and serotype Ic antiserum demonstrated cross-reactions with types Ia and Ib which were explainable by known shared antigens among these types. The only other cross-reaction which resulted in greater than 1 log 10 reduction in colony-forming units was when unabsorbed antiserum to strain Ia was used to opsonize a strain of serotype III. Opsonization of 10 serotype III strains was demonstrated with a single type III antiserum. Killing of nine of these strains required polymorphonuclear leukocytes, complement, and antiserum, but one strain, D136C, the reference strain, could be killed (greater than 1 log 10 reduction in colony-forming units) without either complement or specific antiserum. Inhibition studies were performed utilizing large m.w. polysaccharide antigens extracted from each serotype. These antigens inhibited opsonization of homologous strains by homologous antisera with 50% inhibition points ranging between 0.5 and 4 mug.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65433

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  82 in total

1.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.

Authors:  S Takahashi; Y Nagano; N Nagano; O Hayashi; F Taguchi; Y Okuwaki
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.

Authors:  N J Levy; D L Kasper
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.

Authors:  G W Fischer; S R Wilson; K W Hunter
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

6.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; A K Rodewald; A A Shroff; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci.

Authors:  M R Wessels; J B Goldberg; A E Moses; T J DiCesare
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  The orphan response regulator CovR: a globally negative modulator of virulence in Streptococcus suis serotype 2.

Authors:  Xiuzhen Pan; Junchao Ge; Ming Li; Bo Wu; Changjun Wang; Jing Wang; Youjun Feng; Zhimin Yin; Feng Zheng; Gong Cheng; Wen Sun; Hongfeng Ji; Dan Hu; Peiju Shi; Xiaodan Feng; Xina Hao; Ruiping Dong; Fuquan Hu; Jiaqi Tang
Journal:  J Bacteriol       Date:  2009-01-30       Impact factor: 3.490

10.  Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  M R Wessels; L C Paoletti; A K Rodewald; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.